These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1654074)

  • 1. Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.
    Fayers PM; Bleehen NM; Girling DJ; Stephens RJ
    Br J Cancer; 1991 Aug; 64(2):299-306. PubMed ID: 1654074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.
    Respir Med; 1989 Jan; 83(1):51-8. PubMed ID: 2479963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.
    Geddes DM; Dones L; Hill E; Law K; Harper PG; Spiro SG; Tobias JS; Souhami RL
    Eur J Cancer; 1990 Apr; 26(4):484-92. PubMed ID: 2162692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer.
    Gower NH; Rudd RM; Ruiz de Elvira MC; Spiro SG; James LE; Harper PG; Souhami RL
    Ann Oncol; 1995 Jul; 6(6):575-80. PubMed ID: 8573537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B.
    Ahles TA; Silberfarb PM; Rundle AC; Holland JC; Kornblith AB; Canellos GP; Green MR; Perry MC
    Psychother Psychosom; 1994; 62(3-4):193-9. PubMed ID: 7846263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.
    Br J Cancer; 1996 Feb; 73(3):406-13. PubMed ID: 8562352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Gregor A; Leonard RC; Machin D; McKenzie CG; Morgan DA; Smyth JF; Spittle MF; Stephens RJ
    Br J Cancer; 1991 Oct; 64(4):775-9. PubMed ID: 1654988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
    Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
    Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.
    Br J Cancer; 1989 Apr; 59(4):584-90. PubMed ID: 2540789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
    James LE; Gower NH; Rudd RM; Spiro SG; Harper PG; Trask CW; Partridge M; Ruiz de Elvira MC; Souhami RL
    Br J Cancer; 1996 Jun; 73(12):1563-8. PubMed ID: 8664131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party.
    Stephens RJ; Girling DJ; Machin D
    Lung Cancer; 1994 Sep; 11(3-4):259-74. PubMed ID: 7812703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.
    Ahles TA; Silberfarb PM; Herndon J; Maurer LH; Kornblith AB; Aisner J; Perry MC; Eaton WL; Zacharski LL; Green MR; Holland JC
    J Clin Oncol; 1998 May; 16(5):1954-60. PubMed ID: 9586915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
    J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supportive care during chemotherapy for lung cancer in daily practice].
    Müller V; Tamási L; Gálffy G; Losonczy G
    Magy Onkol; 2012 Sep; 56(3):159-65. PubMed ID: 23008823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Bacchi M; Joss RA; Cavalli F; Senn HJ; Leyvraz S; Stahel R; Ludwig C; Alberto P
    Br J Cancer; 1996 Nov; 74(10):1660-7. PubMed ID: 8932352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
    Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
    J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.
    Hopwood P; Stephens RJ
    J Clin Oncol; 2000 Feb; 18(4):893-903. PubMed ID: 10673533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.